Considering these findings, we speculate that CTLs antigen recognition becomes compromised due to B2M mutation/deletion, while other immune cells such as CD4+ T lymphocytes, NK cells, and γδ T cells may continue to exert cytotoxic effects on tumor cells (64, 70–74, 80). The gene discussed is B2M; the disease is neoplasm.